TCS Digital AI

AI in Pharmacovigilance — Re-imagining the ICSR processing

Over the last few decades, we have seen a spurt of medicines approved by regulatory authorities which have necessitated an increase in the need for monitoring drugs. Pharmacovigilance, is an arm of medical science which deals with gathering, monitoring and assessing the safety of drugs. It has gained increased focus and prominence, over the last decade. It’s thus not a …

Re-Imagining Drug Safety Powered by Genomics, Information Integration and Emerging Technologies

|| Whitepaper by Tata Consultancy Services. Pub. 17/08/2017 Abstract Scientific advancements, emerging technologies, and extensive information have created new opportunities for modernizing drug safety.  Simultaneously, the pharmacovigilance regulatory landscape is shifting to ensure improved safety for patients. This is the time to reimagine the  drug safety sector to transform it into an advanced, proactive and patient-centric practice. Introduction The global …

Drug Safety Europe 2016

Ensuring Compliance for Cloud: A Risk Management Guide for Life Sciences Organizations

In an effort to manage cost pressures, optimize operational efficiencies, and build robust IT capabilities, the life sciences industry is also shifting to the cloud. However, being a highly regulated industry, players face significant compliance challenges while leveraging the cloud. In addition to managing security risks in a shared computing environment, organizations also need to ensure that regulatory commitments are …

TCS whitepaper

Reimagining the Clinical Trials Process through Digital Disruption

Conventional clinical trial processes require significant time and resources to be invested for data cleaning, monitoring, and reporting to the concerned regulatory authorities. This directly influences the cost of the trial, and thus the time to market. Explore how digitization of clinical trial processes can help transform the clinical research industry. The clinical trials industry manages large volumes of patient data …

Tata Consultancy Services whitepaper

Managing Regulatory Compliance in the Pharmaceutical Industry

Changes in regulation, alongside the introduction of stringent anti-corruption legislation, are forcing pharmaceutical companies to renew their focus on compliance. Globally, pharma organizations have to embrace a holistic approach. This involves aligning complex and disparate risks and regulatory compliance activities to the overall corporate strategy. The Increased Risks in Regulatory Compliance The pharmaceutical industry is coming under increased scrutiny across …

Download: The New Frontier for the Pharmaceutical and Life Sciences Industry- Real Big Value from Big Data

  Technological growth and easy access to sophisticated gadgets have led to a digital data explosion. The life sciences industry is no exception, with its top priority being to improve the quality of human health and well being. Big Data helps achieve this by leveraging innovative techniques to enhance productivity in R&D, and reducing the cycle time for drug development …

Re-Imagining Drug Safety Powered by Genomics, Information Integration and Emerging Technologies

The global healthcare environment is undergoing transformation across the care delivery eco-system to provide more affordable and quality healthcare to all. The paper focusses on the next-generation drug safety models, and outlines the direction for realizing the emerging vision. Scientific advancements, emerging technologies and availability of large amount of information from different sources are offering newer opportunities for modernizing drug …

tcs, drug safety, genomics, technology, world drug safety congress europe

Re-imagining Drug Safety

Re-imaginging Drug Safety: Powered by Genomics, Information Integration & Emerging Technologies by Debashis Ghosh, President – Life Science, Manufacturing and Energy, Tata Consultancy Services The video covers: Changing context Genomics and drug safety Information and insights integration Next generation drug safety architecture using emerging technologies Regulatory direction Putting it all together For more information on Drug Safety, join us at the …

Tata, TCS, whitepaper, innovation, R&D, pharma

Download TCS Whitepaper: (P)re-scribing the Innovation Pathway

Over the past decade, pharmaceutical companies have progressively turned to outsourcing to achieve their organizational and R&D goals. The main objectives have been cost savings and crunching cycle times. Today, the outsourcing of R&D processes, including patient-facing and back-end processes, accounts for nearly a quarter of the industry’s R&D spend.  IT service providers present a compelling value proposition in clinical …

Download Whitepaper: Leveraging Emerging Technologies to Improve Patient Centricity in Clinical Trials

Today, the pharmaceutical industry faces many challenges related to patient participation and their involvement in the clinical development process. Tata Consultancy Services (TCS) has provided this whitepaper entitled “Leveraging emerging technologies to improve patient centricity in clinical trials”, which provides an overview of emerging technologies to overcome these challenges in enhancing patient centricity. Download this whitepaper and learn: Clinical Trials: Patient-related …